1. "Biostatistics Service"
  2. "Nancy Kernan"
  3. "Pediatric Leukemia"
Formats
  1. Journal Article (11)
  2. Meeting Abstract (5)
Groups
  1. Biostatistics Service (16)
  2. Center for Hematologic Malignancies (16)
  3. Epidemiology and Biostatistics (16)
  4. Pediatric Leukemia (16)
  5. Pediatrics, Department of (16)
  6. Stem Cell Transplantation and Cellular Therapy Service (16)

More Groups

People
  1. Nancy Kernan (16)
  2. Farid Boulad (12)
  3. Richard O'Reilly (11)
  4. Glenn Heller (10)
  5. Esperanza Papadopoulos (8)
  6. Rachel Kobos (8)

More People

Years
  1. 2022 (2)
  2. 2021 (1)
  3. 2020 (1)
  4. 2019 (1)
  5. 2017 (1)
  6. 2015 (1)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (5)
  2. Blood (2)
  3. Bone Marrow Transplantation (2)
  4. Journal of Clinical Oncology (2)
  5. Blood Advances (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. Elsevier Inc. (6)
  2. American Society of Hematology (3)
  3. American Society of Clinical Oncology (2)
  4. Nature Publishing Group (2)
  5. American Society for Clinical Investigation (1)
  6. John Wiley & Sons (1)

More Publishers

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML
    Journal Article

    Ramaswamy, K.; Steinherz, P. G.; Agrawal, A. K.; Forlenza, C. J.; Mauguen, A.; Roshal, M.; Trippett, T.; Kernan, N. A.; Sulis, M. L.; Shukla, N.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Impact of bridging chemotherapy on clinical outcomes of CD19-specific CAR T cell therapy in children/young adults with relapsed/refractory B cell acute lymphoblastic leukemia
    Journal Article

    Shahid, S.; Ramaswamy, K.; Flynn, J.; Mauguen, A.; Perica, K.; Park, J. H.; Forlenza, C. J.; Shukla, N. N.; Steinherz, P. G.; Margossian, S. P.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Bridging chemotherapy prior to CD19-specific CAR T-cell therapy in children/young adults with relapsed/refractory acute lymphoblastic leukemia
    Meeting Abstract

    Shahid, S.; Ramaswamy, K.; Flynn, J.; Mauguen, A.; Boelens, J. J.; Forlenza, C.; Kernan, N.; Shukla, N.; Steinherz, P.; Sulis, M. L.; more...
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Cardiovascular risk factors in survivors of childhood hematopoietic cell transplantation treated with total body irradiation: A longitudinal analysis
    Journal Article

    Friedman, D. N.; Hilden, P.; Moskowitz, C. S.; Suzuki, M.; Boulad, F.; Kernan, N. A.; Wolden, S. L.; Oeffinger, K. C.; Sklar, C. A.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Barker, J.; Castro-Malaspina, H.; Curran, K.; Giralt, S.; Hasan, A.; Heller, G.; Hsu, K.; Jakubowski, A.; more...
    Bone Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Do patients with high risk or relapsed core binding factor acute myeloid leukemia benefit from salvage allogeneic stem cell transplantation?
    Meeting Abstract

    Hobbs, G.; Kishtagari, A.; Hilden, P.; Barker, J. N.; Jakubowski, A. A.; Papadopoulos, E.; Devlin, S.; Boulad, F.; Kernan, N.; Kobos, R.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Klein, E. G.; Barker, J. N.; Castro-Malaspina, H. R.; Curran, K. J.; Giralt, S. A.; Goldberg, J. D.; Hasan, A. N.; Heller, G.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Double-unit cord blood transplantation (DCBT) for acute leukemia: High disease-free survival in adults and children with comparable survival in European and minority patients
    Meeting Abstract

    Barker, J. N.; Ponce, D.; Devlin, S.; Lubin, M.; Evans, K.; Gonzales, A. M.; Castro-Malaspina, H.; Giralt, S. A.; Goldberg, J.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save